Cours Nemus Bioscience Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 365 M 331 M |
---|---|---|---|---|---|
Résultat net 2024 * | -23 M -20,84 M | Résultat net 2025 * | -34 M -30,81 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-16,6
x | PER 2025 * |
-14,9
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,92% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19/01/18 |
Director of Finance/CFO | - | 05/10/21 | |
Chief Tech/Sci/R&D Officer | 52 | 13/12/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 77 | 07/08/20 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 22/07/21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 18/08/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+21,89% | 47,9 Md | |
+46,56% | 41,42 Md | |
-2,37% | 40,7 Md | |
-6,20% | 28,92 Md | |
+10,96% | 25,55 Md | |
-21,58% | 19,27 Md | |
-1,55% | 12,15 Md | |
+30,51% | 12,14 Md | |
-0,63% | 11,99 Md |